ALS Limited (ASX:ALQ) produces resilient H1 FY25 result despite mixed market conditions

18 NOV 2024
READ MORE

Recent stories

 

Featured stories

Sights are set high for ALS’ Assay & Inspection

  READ MORE

Extractables & Leachables Testing Partner

  READ MORE

ALS strategically expands its Life Sciences presence

  READ MORE

Other stories